Pharma Industry News: June 2003

June 1	Focus on Arthritis
June 1	Study: Oxaliplatin significantly decreases the risk of relapse after surgery from colorectal cancer
June 2	Iressa demonstrates clinical activity in multiple tumour types
June 3	Erbitux offers hope to patients with carcinoma of the head and neck or nasopharyngeal carcinoma
June 5	SARS
June 12	FDA discusses pediatric drug safety with its advisory subcommittee under BPCA
June 13	FDA approves Stalevo for treatment of Parkinson's Disease -- reduces signs and symptoms
June 13	FDA issues generic drug final rules
June 16	FDA approves UroXatral for benign prostatic hyperplasia symptoms treatment
June 17	Promising results shorten UK Lipitor trial in type 2 diabetes patients by two years
June 17	British Columbia approval of Pegetron for hepatitis C completes Canada-wide coverage
June 17	FDA approves needle-free FluMist -- first flu vaccine delivery innovation in over 50 years
June 17	Stanford research finds better results in newer antipsychotic medicines
June 17	Study shows type-2 diabetes drug rosiglitazone may limit heart disease risk
June 17	PhRMA tells senators patent incentives for discovery of new medicines must be maintained
June 17	Investigational new drug status cleared by FDA for phenoxodiol in oral form
June 17	Yale study shows lofexidine is effective in preventing opiate addiction relapse
June 17	Curacyte scientists discover new anti-tumor agents
June 17	drugstore.com. reaches 2 million prescriptions as savings and convenience drive acceptance
June 17	ASHP Policy Positions: Causes of and solutions to drug product shortages
June 25	FDA approves first co-packaged treatments to reduce occurrence of serious cardiovascular and cerebrovascular events
June 25	CBER warns Allergan again about Botox ads
June 26	House Committee probes Medicaid fraud, contacts 26 drug companies, 3 wholesalers
June 26	Pfizer experimental compounds being investigated for utility in malaria, SARS, smallpox
June 26	Fast-track designation for Avastin in first-line metastatic colorectal cancer treatment
June 27	Able Labs receives approval for metronidazole tablets USP 250mg and 500mg
June 30	Corixa and GlaxoSmithKline announce FDA approval of Bexxar
June 30	Blue Cross and Blue Shield Plans act in response to 'pharmaceutical industry promo tactics'
June 30	Law firm to file suit on behalf of victims of Accutane side effects
June 30	FDA accepts for review new drug application for trospium
June 30	Protecting public health: FDA pursues an aggressive enforcement strategy

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jul | Aug | Sep | Oct | Nov | Dec
2003: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2002: Jan | Apr | May | Jun | Aug | Sep | Oct | Nov | Dec

Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals